Drugs / Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)
Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01412385 Background | Jun 2011 → May 2014 | immunodeficiency disease | Baxalta now part of Shire | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01412385 ↗ |
| Modality | Protein / enzyme biologic | “Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)” NCT01412385 ↗ |
| Route | Subcutaneous | “Subcutaneous infusion (regulated via a pump)” NCT01412385 ↗ |